Aspirin May Protect Gray, White Matter

ATLANTA — Aspirin, even at low doses, appears to prevent age-related declines in gray and white matter integrity in brain regions that typically show the earliest neuropathological changes associated with Alzheimer's disease, according to Lee Ryan, Ph.D., of the departments of psychology and neuroscience of the University of Arizona at Tucson, who presented her findings at the annual meeting of the Society for Neuroscience.